SOPH earnings date and last-quarter result: last quarter miss, P/E -5.42. Updated 2026-07-23.
SOPHiA GENETICS (SOPH) Research Hub
SOPHiA GENETICS (SOPH) trades on NASDAQ, CH in the Healthcare (Medical - Healthcare Information Services) sector. As of 2026-10-26, shares last closed at 7.52 USD (+2.31%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -5.42, market cap 0.45B. This hub links to the full technical, earnings and options research available for SOPH.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Healthcare Information Services) |
|---|---|
| Exchange | NASDAQ, CH |
| Last close | 7.52 USD (+2.31%) |
| 52-week range | 4.89 USD – 8.91 USD |
| Trend regime | Range |
| 14-day RSI | 52 (Neutral) |
| Trailing P/E | -5.42 |
| Market cap | 0.45B |
| Dividend yield | 0.00% |
Available research for SOPH
Covered Call on SOPH: how it works, illustrative setup around the real 7.52 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on SOPH: how it works, illustrative setup around the real 7.52 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on SOPH: how it works, illustrative setup around the real 7.52 USD price, max profit/loss, breakeven and when to use it. Educational.
SOPH technical analysis: range, last 7.52 USD, RSI 52, 52w range 4.89 USD–8.91 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is SOPH in?
SOPHiA GENETICS (SOPH) is classified under Healthcare (Medical - Healthcare Information Services), listed on NASDAQ, CH.
Is SOPH in an uptrend or downtrend?
As of 2026-10-26, SOPH is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is SOPH's trailing P/E ratio?
SOPH's trailing P/E is -5.42, with a market cap of 0.45B. See the earnings research page for full valuation detail.